MétaCan
← tous les travaux

Proliferative Vitreoretinopathy (PVR) Update: Current Surgical Techniques and Emerging Medical Management

2017· article· en· 1 citations· W2604835042 sur OpenAlex· 10.1177/2474126417697592

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Affiliation canadienneUne personne signataire a déclaré un établissement canadien. C'est la seule voie dont dispose la base habituelle.

Le tri à trois modèles

les 1 000 travaux triés →

Les trois modèles l'ont jugé hors champ.

strate : aff_core · poids de sondage : 5595.24 (l'échantillon est stratifié ; tout taux calculé sans le poids est faux)
Claude Opus 4.8OUT
genre : other
porte sur le Canada: non
confiance: high

Clinical narrative review of surgical and medical management of proliferative vitreoretinopathy; the object is patient treatment.

GPT-5.6 (high)OUT
genre : conceptual
porte sur le Canada: non
confiance: high

This review addresses clinical management of retinal disease rather than evidence-synthesis methodology.

Grok 4.5OUT
genre : other
porte sur le Canada: non
confiance: high

Clinical literature update on PVR surgical and medical management, not methods of research.

Résumé

Purpose: To provide an update on current surgical techniques and emerging medical management in proliferative vitreoretinopathy (PVR). Methods: A literature search was conducted on studies in the past decade with the inclusion of historical, landmark studies. Results: Proliferative vitreoretinopathy remains the primary obstacle to successful retinal detachment (RD) surgery, despite increasing knowledge on its pathophysiology and efforts to reduce its occurrence. A number of recent visualization and surgical advancements, including smaller gauge vitrectomies, have shown promising results. Likely, effective PVR prevention and treatment may rest on a multimodal approach, with particular attention toward adjunct pharmacological use. There is a growing body of literature on effective anti-inflammatory, antineoplastic/proliferative, antigrowth factor, and antioxidant adjunct therapy. Nonetheless, a number of preoperative and perioperative risk factors must be assessed before considering any surgical or medical management. Newer preoperative risk factor findings, such as smoking, highlight the need for a broad consideration during patient counseling. Discussion: Most studies in this field are retrospective in design, and the number of randomized control trials is limited, owing to the uncommon nature and complicated clinical profiles of patients with PVR RDs. Prospective studies should consider including combination drug formulations as a part of its intervention. Surgical techniques that may mitigate the inflammatory response by reducing ocular trauma should also continue to be investigated.

Conservé avec la notice de tri, où il sert de preuve aux étiquettes ci-dessus.

La notice

Revue
Journal of VitreoRetinal Diseases
Thématique
Retinal and Macular Surgery
Domaine
Medicine
Établissements canadiens
Queen's University
Organismes subventionnaires
Mots-clés
MedicineProliferative vitreoretinopathyPerioperativeIntensive care medicineRetinal detachmentClinical trialRandomized controlled trialSurgeryOphthalmologyRetinalPathology
Résumé présent dans OpenAlex
oui